Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) is now available.
WuXi AppTec Co., Ltd. has announced that its board of directors will meet on July 28, 2025, to review and approve the unaudited interim results for the first half of the year ending June 30, 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical and biotechnology industry. The company, along with its subsidiaries, focuses on providing comprehensive laboratory and manufacturing services to support the pharmaceutical, biotech, and medical device industries globally.
Average Trading Volume: 6,880,306
Technical Sentiment Signal: Buy
Current Market Cap: HK$238.4B
For a thorough assessment of 2359 stock, go to TipRanks’ Stock Analysis page.